Cognition Therapeutics Raises Series A
Cognition Therapeutics Inc., a Pittsburgh-based developer of treatments for Alzheimer's Disease, has raised $1.21 million in Series A funding. Ogden CAP led the round, and was joined by M5Invest Partners, Pittsburgh Life Sciences Greenhouse, Innovation Works and individual angels.
16 July 2009•5 mins read
